Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
- R. Bruno, D. Hille, +14 authors L. Sheiner
- Journal of clinical oncology : official journal…
PURPOSE The population pharmacokinetic/pharmacodynamic (PK/PD) approach was prospectively integrated in the clinical development of docetaxel to assess the PK profile in a large population of… Expand
The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication.
- A. Behar, É. Pujade-Lauraine, +5 authors D. Hille
- British journal of clinical pharmacology
- 1 June 1997
AIMS Fluid retention is a phenomenon associated with taxoids. The principal objective of this study was to investigate the pathophysiological mechanism of docetaxel-induced fluid retention in… Expand
Pharmacokinetic and pharmacodynamic properties of docetaxel: results of phase I and phase II trials.
- R. Bruno, A. Riva, D. Hille, A. Lebecq, L. Thomas
- American journal of health-system pharmacy : AJHP…
- 1 December 1997
The pharmacokinetics of docetaxel as investigated in Phase I and Phase II trials are discussed. Phase I trials have shown that docetaxel exhibits linear pharmacokinetics consistent with a… Expand
A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis.
- W. Howland, R. Dockhorn, +6 authors J. Smith
- The Journal of allergy and clinical immunology
- 1 July 1996
BACKGROUND One of the risks associated with the use of oral corticosteroids is suppression of adrenocortical function. Triamcinolone acetonide (TAA) aqueous nasal spray administered once daily (110… Expand
Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
- M. Notelovitz, D. Cassel, +4 authors D. Skarinsky
- American journal of obstetrics and gynecology
OBJECTIVE This study was undertaken to evaluate the efficacy and tolerability of a combination estradiol plus norethindrone acetate transdermal delivery system given in a continuous sequential… Expand
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
SummaryBackground MK-5108 is a potent/highly selective Aurora A kinase inhibitor. Methods A randomized Phase I study of MK-5108, administered p.o. BID Q12h on days 1–2 in 14–21 day cycles either… Expand
P-74. Double-Blind, Randomized, Placebo-Controlled Trial of Combined Sequential Transdermal HRT on Vasomotor Symptoms